|Up to $6
|Up to $20
|Up to $65
Dragon Pharma CJC-1295 peptide with DAC, also known as DAC:GRF. Is an intriguing synthetic mimic of a segment of naturally produced growth hormone releasing hormone (GHRH).
The chemistry of CJC-1295 with DAC peptide revolves around the initial 29 building blocks of endogenously produced GHRH. Since these amino acids offer complete biological activity.
But this peptide goes a step further by incorporating four amino acid substitutions to enhance stability and potency when compared to previous versions of CJC-1295 without DAC.
This modification enables the peptide to permanently bind to the protein albumin inside the body. Reducing peptide degradation and oxidation for improved stability.
Additionally, these extra amino acids enhance the peptide's affinity for the GHRH receptor, increasing its potency. GHRH plays a vital role in natural growth hormone secretion and achieving optimal growth during development.
Dragon Pharma CJC-1295 stimulates growth hormone secretion by binding to GHRH receptors and promotes the secretion of various growth hormone peptides released by the pituitary gland. These peptides stimulate bone density, collagen production, and boost the immune system. They also encourage the development of lean muscle mass.
For enhanced peptide cycling results, CJC-1295 with DAC can be combined with growth hormone releasing peptides. Common pairings include CJC-1295 DAC with growth hormone replacement peptide (GHRP) 6 or GHRP-2.
The combination of CJC-1295 DAC with GHRP can accelerate fat loss, weight loss, and induce anabolic effects through growth hormone induced fat breakdown.
Overall, CJC-1295 with DAC stimulates protein synthesis, promotes the growth of lean muscle tissue, accelerates injury recovery, reduces body fat, and increases muscle mass.
Dragon Pharma CJC 1295 DAC, with its growth stimulatory properties, not only enhances skin health, healing, and immune system function but also promotes cell growth and division. It is important to note that CJC-1295 DAC and CJC-1295 without DAC must not be confused as they have different chemical properties and affect dosing differently.
When injecting CJC 1295 DAC subcutaneously, a weekly dose of 100 mcg or 200 mcg can be administered due to its extended half-life of approximately 8 days.
By following this CJC 1295 DAC peptide cycling strategy, a sustained increase in growth hormone can be achieved.
Additionally, it can be stacked with other GHRPs such as GHRP-6 or GHRP-2.